LEWIS GEFFEN

Profile

First Name

: LEWIS

Middle Name

:

Last Name

: GEFFEN

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
DECIMMUNE THERAPEUTICS INC
MICHAEL C. CARROLL, PH.D., RICHARD S. FOEMMEL, PH.D., LEWIS J. GEFFEN, CHRISTOPHER K. MIRABELLI, PH.D., JANIS C. NAEVE, PH.D., HAROLD R. WERNER
EXECUTIVE OFFICER
TARSA THERAPEUTICS, INC.
ERIC BEDNARSKI, DAVID BRAND, MARTIN EDWARDS, DEREK FERGUSON, RICHARD KOLLENDER, RICHARD LEVY, GREGORY LUMPKIN, ASHLEIGH PALMER, MATTHEW RIEKE, JAMES TANANBAUM
EXECUTIVE OFFICER
SYNLOGIC, INC.
PETER BARRETT, AOIFE BRENNAN, DANIEL GEFFKEN, JOSE CARLOS GUTIERREZ-RAMOS, CHAU KHUONG, NICK LESCHLY, ANKIT MAHADEVIA, ED MATHERS, PAUL MILLER, TODD SHEGOG
EXECUTIVE OFFICER
AMBIO HOLDINGS, INC.
JUNCAI BAI, BOSUN HAU, STEPHEN KIEL, STEPHEN REEDERS
EXECUTIVE OFFICER
LUMEN LABS INC.
EU-WEN DING
EXECUTIVE OFFICER
OPSONIX, INC.
ERIC J DEVROE, ERIC J. DEVROE, DANIEL GEFFKEN, BRIAN PEREIRA, BRIAN J. G. PEREIRA, PRIYANKA ROHATGI, ANNE SISSEL, ANDREW STEVENSON
EXECUTIVE OFFICER
SYNLOGIC, LLC
PETER BARRETT, BHARATT CHOWRIRA, JOSE CARLOS GUTIERREZ-RAMOS, CHAU KHUONG, ANKIT MAHADEVIA, ED MATHERS, MICHAEL SHEAHAN
EXECUTIVE OFFICER
AURA BIOSCIENCES, INC.
JOSE BASELGA, PH.D., JOSE- BASELGA, PH.D., LAWRENCE C. BEST, CASPER BREUM, MARK CHIN, ELISABET DE LOS PINOS, PH.D., JULIE FEDER, PETER FINN, PETER B. FINN, JAVIER GARCIA, SALVADOR GARCIA-ATANCE, GEORGE GOLUMBESKI, PH.D., PEDRO GRANADILLO, JOEL JEAN-MAIRET, PH.D., DAVID JOHNSON, SEBASTIAN JULIA, GIOVANNI MARIGGI, PH.D., EDMUNDO MUNIZ, M.D., PH.D., ART PAPPAS, RAJ PAREKH, PH.D., DALE PFOST, PH.D., ISRAEL RUIZ, CHRISTIAN SCHETTER, KARAN TAKHAR, HENRI TERMEER, ALAN WALTS, ALAN WALTS, PH.D., ALAN E. WALTS, PH.D., PETER WIRTH, MICHAEL WYZGA
EXECUTIVE OFFICER
UNRAVEL BIOSCIENCES, INC.
DONALD INGBER, RICHARD NOVAK, FREDERIC VIGNEAULT
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-08-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-23 
2019-04-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-01 
2018-12-13
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-20 
2018-02-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-10-27 
2018-01-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-20 
2017-11-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-10-27 
2017-11-02
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-09-15 
2017-05-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-15 
2017-01-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-12-29 
2016-09-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-09-15 
2016-07-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-06-29 
2016-02-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-11 
2016-02-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-11 
2016-02-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-02-05 
2015-10-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-23 
2015-01-27
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2015-01-15 
2014-11-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-05 
2014-07-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-07-07 
2012-03-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-13 
2010-09-17
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2010-09-03